Krop I - Search Results

1

A putative role for psoriasin in breast tumor progression.

Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. Krop I, et al. Cancer Res. 2005 Dec 15;65(24):11326-34. doi: 10.1158/0008-5472.CAN-05-1523. Cancer Res. 2005. PMID: 16357139

2

A SAGE (serial analysis of gene expression) view of breast tumor progression.

Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K. Porter DA, et al. Among authors: krop ie. Cancer Res. 2001 Aug 1;61(15):5697-702. Cancer Res. 2001. PMID: 11479200

3

HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.

Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K. Krop IE, et al. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. doi: 10.1073/pnas.171138398. Epub 2001 Jul 31. Proc Natl Acad Sci U S A. 2001. PMID: 11481438 Free PMC article.

4

Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression).

Seth P, Krop I, Porter D, Polyak K. Seth P, et al. Among authors: krop i. Oncogene. 2002 Jan 24;21(5):836-43. doi: 10.1038/sj.onc.1205113. Oncogene. 2002. PMID: 11850811

5

Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.

Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, Johannsdottir HK, Nevanlinna H, Borg A, Gelman R, Barkardottir RB, Lindblom A, Polyak K. Krop I, et al. Cancer Res. 2003 May 1;63(9):2024-7. Cancer Res. 2003. PMID: 12727813

6

Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.

Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K. Krop I, et al. Mol Cancer Res. 2004 Sep;2(9):489-94. Mol Cancer Res. 2004. PMID: 15383627

7

HIN-1, an inhibitor of cell growth, invasion, and AKT activation.

Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K. Krop I, et al. Cancer Res. 2005 Nov 1;65(21):9659-69. doi: 10.1158/0008-5472.CAN-05-1663. Cancer Res. 2005. PMID: 16266985

8

Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.

Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K. Kleer CG, et al. Clin Cancer Res. 2008 Sep 1;14(17):5357-67. doi: 10.1158/1078-0432.CCR-08-0732. Clin Cancer Res. 2008. PMID: 18765527 Free PMC article.

9

Mechanisms of trastuzumab resistance in breast cancer.

Tolaney SM, Krop IE. Tolaney SM, et al. Anticancer Agents Med Chem. 2009 Mar;9(3):348-55. doi: 10.2174/1871520610909030348. Anticancer Agents Med Chem. 2009. PMID: 19275526 Review.

10

Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.

Yang XH, Flores LM, Li Q, Zhou P, Xu F, Krop IE, Hemler ME. Yang XH, et al. Cancer Res. 2010 Mar 15;70(6):2256-63. doi: 10.1158/0008-5472.CAN-09-4032. Epub 2010 Mar 2. Cancer Res. 2010. PMID: 20197472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters